Pre-Clinical Investigation of Keratose as an Excipient of Drug Coated Balloons

Background: Drug-coated balloons (DCBs), which deliver anti-proliferative drugs with the aid of excipients, have emerged as a new endovascular therapy for the treatment of peripheral arterial disease. In this study, we evaluated the use of keratose (KOS) as a novel DCB-coating excipient to deliver a...

Descripción completa

Detalles Bibliográficos
Autores principales: Goel, Emily, Erwin, Megan, Cawthon, Claire V., Schaff, Carson, Fedor, Nathaniel, Rayl, Trevor, Wilson, Onree, Christians, Uwe, Register, Thomas C., Geary, Randolph L., Saul, Justin, Yazdani, Saami K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180741/
https://www.ncbi.nlm.nih.gov/pubmed/32244375
http://dx.doi.org/10.3390/molecules25071596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180741/
https://www.ncbi.nlm.nih.gov/pubmed/32244375
http://dx.doi.org/10.3390/molecules25071596

Ejemplares similares